---
schema_version: "secwatch.filing_event.v1"
accession: "0001193125-22-105541"
form_type: "8-K"
ticker: "IOBTQ"
cik: "0001865494"
company_name: "IO Biotech, Inc."
filed_at: "2022-04-14T23:59:59+00:00"
generated_at: "2026-06-26T07:28:26.862001+00:00"
event_type: "leadership"
sentiment: "neutral"
materiality_score: 0.3
calibrated_materiality_score: 0.3
confidence: "high"
source: SEC EDGAR
---

# Two IO Biotech directors to step down at 2022 annual meeting

## Summary
- Dr. Claus Andersson and Dr. Emmanuelle Coutanceau notified the Board they will not stand for reelection.
- Effective at the Company's 2022 annual meeting of stockholders.
- Decisions are not due to any disagreement with the Company or Board regarding operations, policies, or practices.

## SEC filing metadata
- accession: 0001193125-22-105541
- form_type: 8-K
- ticker: IOBTQ
- cik: 0001865494
- company_name: IO Biotech, Inc.
- filed_at: 2022-04-14T23:59:59+00:00
- event_type: leadership
- sentiment: neutral
- materiality_score: 0.3
- calibrated_materiality_score: 0.3
- confidence: high
- sec_items: 5.02
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1865494/000119312522105541/0001193125-22-105541-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1865494/000119312522105541/d299788d8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001193125-22-105541
- JSON: https://secwatch.observer/filing/0001193125-22-105541.json
- Plain text: https://secwatch.observer/filing/0001193125-22-105541.txt

## Key facts
- Executive change
  Claus Andersson departed as Director at IO Biotech, Inc..
  - Action: will not stand for reelection
  - Role: Director
  source text: On April 12, 2022, Dr. Claus Andersson, a director of the board of directors (the “Board”) of the IO Biotech, Inc. (the “Company”), notified the Company that he will not stand for reelection at the Company’s 2022 annual meeting of stockholders.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1865494/000119312522105541/0001193125-22-105541-index.htm
- Executive change
  Emmanuelle Coutanceau departed as Director at IO Biotech, Inc..
  - Action: will not stand for reelection
  - Role: Director
  source text: On the same date, Dr. Emmanuelle Coutanceau, a director of the Board, notified the Company that she will not stand for reelection at the Company’s 2022 annual meeting of stockholders.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1865494/000119312522105541/0001193125-22-105541-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.